241 related articles for article (PubMed ID: 23799881)
1. INI1/hSNF5-interaction defective HIV-1 IN mutants exhibit impaired particle morphology, reverse transcription and integration in vivo.
Mathew S; Nguyen M; Wu X; Pal A; Shah VB; Prasad VR; Aiken C; Kalpana GV
Retrovirology; 2013 Jun; 10():66. PubMed ID: 23799881
[TBL] [Abstract][Full Text] [Related]
2. An Essential Role of INI1/hSNF5 Chromatin Remodeling Protein in HIV-1 Posttranscriptional Events and Gag/Gag-Pol Stability.
La Porte A; Cano J; Wu X; Mitra D; Kalpana GV
J Virol; 2016 Nov; 90(21):9889-9904. PubMed ID: 27558426
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of early stages of HIV-1 assembly by INI1/hSNF5 transdominant negative mutant S6.
Cano J; Kalpana GV
J Virol; 2011 Mar; 85(5):2254-65. PubMed ID: 21159874
[TBL] [Abstract][Full Text] [Related]
4. Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication.
Sorin M; Cano J; Das S; Mathew S; Wu X; Davies KP; Shi X; Cheng SW; Ott D; Kalpana GV
PLoS Pathog; 2009 Jun; 5(6):e1000463. PubMed ID: 19503603
[TBL] [Abstract][Full Text] [Related]
5. Multimerization and DNA binding properties of INI1/hSNF5 and its functional significance.
Das S; Cano J; Kalpana GV
J Biol Chem; 2009 Jul; 284(30):19903-14. PubMed ID: 19398554
[TBL] [Abstract][Full Text] [Related]
6. Integrase interactor 1 (Ini1/hSNF5) is a repressor of basal human immunodeficiency virus type 1 promoter activity.
Boese A; Sommer P; Holzer D; Maier R; Nehrbass U
J Gen Virol; 2009 Oct; 90(Pt 10):2503-2512. PubMed ID: 19515827
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 replication in cell lines harboring INI1/hSNF5 mutations.
Sorin M; Yung E; Wu X; Kalpana GV
Retrovirology; 2006 Aug; 3():56. PubMed ID: 16945155
[TBL] [Abstract][Full Text] [Related]
8. Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance.
Yung E; Sorin M; Wang EJ; Perumal S; Ott D; Kalpana GV
J Virol; 2004 Mar; 78(5):2222-31. PubMed ID: 14963118
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional role of INI1 and LEDGF in the HIV-1 preintegration complex.
Maillot B; Lévy N; Eiler S; Crucifix C; Granger F; Richert L; Didier P; Godet J; Pradeau-Aubreton K; Emiliani S; Nazabal A; Lesbats P; Parissi V; Mely Y; Moras D; Schultz P; Ruff M
PLoS One; 2013; 8(4):e60734. PubMed ID: 23593299
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1.
Yung E; Sorin M; Pal A; Craig E; Morozov A; Delattre O; Kappes J; Ott D; Kalpana GV
Nat Med; 2001 Aug; 7(8):920-6. PubMed ID: 11479624
[TBL] [Abstract][Full Text] [Related]
11. Integrase interactor 1 in health and disease.
Das S
Curr Protein Pept Sci; 2015; 16(6):478-90. PubMed ID: 25772157
[TBL] [Abstract][Full Text] [Related]
12. The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription.
Ariumi Y; Serhan F; Turelli P; Telenti A; Trono D
Retrovirology; 2006 Aug; 3():47. PubMed ID: 16889668
[TBL] [Abstract][Full Text] [Related]
13. Protein-Protein and Protein-RNA Interaction Assays to Determine Similarity of INI1/SMARCB1 and TAR RNA in Binding to HIV-1 Integrase.
Kalpana GV
Methods Mol Biol; 2023; 2610():85-97. PubMed ID: 36534284
[TBL] [Abstract][Full Text] [Related]
14. INI1/SMARCB1 Rpt1 domain mimics TAR RNA in binding to integrase to facilitate HIV-1 replication.
Dixit U; Bhutoria S; Wu X; Qiu L; Spira M; Mathew S; Harris R; Adams LJ; Cahill S; Pathak R; Rajesh Kumar P; Nguyen M; Acharya SA; Brenowitz M; Almo SC; Zou X; Steven AC; Cowburn D; Girvin M; Kalpana GV
Nat Commun; 2021 May; 12(1):2743. PubMed ID: 33980829
[TBL] [Abstract][Full Text] [Related]
15. Interaction between Nef and INI1/SMARCB1 augments replicability of HIV-1 in resting human peripheral blood mononuclear cells.
Pyeon D; Park IW
Arch Virol; 2015 Mar; 160(3):727-37. PubMed ID: 25559666
[TBL] [Abstract][Full Text] [Related]
16. Characterization of DNA binding property of the HIV-1 host factor and tumor suppressor protein Integrase Interactor 1 (INI1/hSNF5).
Das S; Banerjee B; Hossain M; Thangamuniyandi M; Dasgupta S; Chongdar N; Kumar GS; Basu G
PLoS One; 2013; 8(7):e66581. PubMed ID: 23861745
[TBL] [Abstract][Full Text] [Related]
17. Contribution of the C-terminal region within the catalytic core domain of HIV-1 integrase to yeast lethality, chromatin binding and viral replication.
Xu Z; Zheng Y; Ao Z; Clement M; Mouland AJ; Kalpana GV; Belhumeur P; Cohen EA; Yao X
Retrovirology; 2008 Nov; 5():102. PubMed ID: 19014595
[TBL] [Abstract][Full Text] [Related]
18. Non-catalytic site HIV-1 integrase inhibitors disrupt core maturation and induce a reverse transcription block in target cells.
Balakrishnan M; Yant SR; Tsai L; O'Sullivan C; Bam RA; Tsai A; Niedziela-Majka A; Stray KM; Sakowicz R; Cihlar T
PLoS One; 2013; 8(9):e74163. PubMed ID: 24040198
[TBL] [Abstract][Full Text] [Related]
19. Comparative molecular genetic analysis of simian and human HIV-1 integrase interactor INI1/SMARCB1/SNF5.
Pyeon D; Price L; Park IW
Arch Virol; 2015 Dec; 160(12):3085-91. PubMed ID: 26350979
[TBL] [Abstract][Full Text] [Related]
20. Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.
Li X; Koh Y; Engelman A
J Virol; 2012 Apr; 86(7):3861-79. PubMed ID: 22278243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]